CJC-1295 (DAC) is a synthetic peptide analog of growth hormone-releasing hormone (GHRH), developed for research into sustained growth hormone stimulation, metabolic activity, and endocrine function. The inclusion of Drug Affinity Complex (DAC) extends the peptide’s half-life, allowing for prolonged and continuous release of growth hormone in experimental settings. This extended activity makes CJC-1295 (DAC) particularly valuable in research focused on long-term hormone regulation, insulin-like growth factor-1 (IGF-1) levels, and metabolic processes. It is widely studied for its potential effects on body composition, fat metabolism, and recovery mechanisms. Due to its long-acting nature, CJC-1295 (DAC) provides a consistent stimulation of growth hormone pathways, making it suitable for studies examining sustained physiological responses and endocrine system behavior over time.